Your browser is no longer supported. Please, upgrade your browser.
Settings
NUVA NuVasive, Inc. daily Stock Chart
NUVA [NASD]
NuVasive, Inc.
Index- P/E- EPS (ttm)-0.12 Insider Own0.20% Shs Outstand51.22M Perf Week-0.91%
Market Cap2.67B Forward P/E21.21 EPS next Y2.47 Insider Trans-2.86% Shs Float50.90M Perf Month5.92%
Income-3.80M PEG- EPS next Q0.24 Inst Own- Short Float11.56% Perf Quarter-9.50%
Sales1.06B P/S2.51 EPS this Y414.80% Inst Trans0.63% Short Ratio7.99 Perf Half Y-6.89%
Book/sh17.47 P/B3.00 EPS next Y153.80% ROA-0.20% Target Price65.88 Perf Year-22.18%
Cash/sh18.20 P/C2.88 EPS next 5Y10.14% ROE-0.40% 52W Range28.55 - 81.91 Perf YTD-32.21%
Dividend- P/FCF40.83 EPS past 5Y40.30% ROI7.00% 52W High-37.16% Beta1.38
Dividend %- Quick Ratio1.40 Sales past 5Y8.90% Gross Margin70.60% 52W Low80.30% ATR2.19
Employees2800 Current Ratio1.80 Sales Q/Q-30.30% Oper. Margin6.00% RSI (14)48.47 Volatility3.74% 4.16%
OptionableYes Debt/Eq1.54 EPS Q/Q-442.30% Profit Margin-0.40% Rel Volume0.52 Prev Close52.43
ShortableYes LT Debt/Eq0.84 EarningsAug 04 AMC Payout- Avg Volume736.44K Price51.47
Recom2.40 SMA200.80% SMA50-0.87% SMA200-12.36% Volume153,191 Change-1.82%
Oct-20-20Initiated Stifel Buy $64
Jun-25-20Initiated Northland Capital Market Perform $65
Jun-23-20Upgrade Needham Hold → Buy
Apr-08-20Upgrade Robert W. Baird Neutral → Outperform $66
Mar-05-20Initiated Citigroup Neutral $68
Jan-08-20Initiated SunTrust Buy $93
Dec-13-19Upgrade SVB Leerink Mkt Perform → Outperform
Jul-29-19Downgrade Robert W. Baird Outperform → Neutral $66
Feb-12-19Downgrade Jefferies Buy → Hold $60
Feb-08-19Downgrade Needham Buy → Hold
Oct-31-18Reiterated Needham Buy $80 → $75
Oct-17-18Reiterated Needham Buy $67 → $80
Sep-27-18Upgrade Robert W. Baird Neutral → Outperform
Aug-01-18Reiterated Needham Buy $69 → $67
Jun-27-18Downgrade BofA/Merrill Neutral → Underperform
Jun-21-18Downgrade JP Morgan Overweight → Neutral
Jun-01-18Initiated Cantor Fitzgerald Neutral
May-02-18Reiterated Needham Buy $70 → $69
Apr-04-18Initiated Goldman Neutral $47
Feb-27-18Reiterated Needham Buy $71 → $70
Oct-20-20 09:56AM  
Oct-19-20 04:03PM  
Oct-14-20 04:02PM  
Oct-13-20 08:36AM  
Oct-12-20 11:40AM  
Oct-09-20 11:42AM  
Oct-05-20 08:33AM  
Sep-25-20 10:34AM  
Sep-14-20 03:15PM  
Sep-09-20 08:33AM  
Sep-03-20 11:31AM  
Aug-31-20 04:03PM  
Aug-24-20 08:52AM  
Aug-06-20 10:21AM  
Aug-05-20 01:52PM  
01:31AM  
Aug-04-20 05:15PM  
04:03PM  
Jul-29-20 12:10PM  
Jul-28-20 12:33PM  
Jul-22-20 08:33AM  
Jul-21-20 01:37AM  
Jul-20-20 04:05PM  
Jul-17-20 08:33AM  
Jul-16-20 07:05PM  
Jun-22-20 11:08AM  
09:24AM  
Jun-18-20 08:33AM  
Jun-15-20 06:01PM  
05:40PM  
03:05PM  
Jun-05-20 11:31AM  
10:53AM  
Jun-04-20 04:10PM  
May-28-20 12:18AM  
May-26-20 04:02PM  
May-19-20 08:33AM  
May-12-20 04:03PM  
May-11-20 09:28AM  
May-07-20 04:00PM  
10:53AM  
May-06-20 06:35PM  
04:02PM  
May-05-20 08:33AM  
May-04-20 04:03PM  
Apr-29-20 12:34PM  
Apr-16-20 08:36AM  
Apr-14-20 04:02PM  
Apr-13-20 07:24AM  
Apr-06-20 04:14PM  
Apr-05-20 07:36PM  
Apr-01-20 03:00PM  
Mar-24-20 05:09PM  
11:24AM  
Mar-23-20 11:24AM  
Mar-10-20 11:22AM  
08:33AM  
Mar-09-20 09:20AM  
Mar-02-20 08:33AM  
Feb-28-20 02:53PM  
Feb-27-20 04:03PM  
02:11AM  
12:32AM  
Feb-26-20 08:05AM  
Feb-23-20 09:09AM  
Feb-21-20 08:32AM  
Feb-20-20 04:02PM  
Feb-13-20 08:33AM  
Feb-11-20 08:30AM  
Feb-04-20 04:03PM  
Jan-24-20 09:55AM  
Jan-23-20 08:23AM  
Jan-20-20 12:10PM  
09:13AM  
Jan-16-20 10:01AM  
Jan-15-20 10:50AM  
Jan-14-20 04:41AM  
03:59AM  
Jan-13-20 10:16AM  
08:33AM  
08:14AM  
Jan-10-20 11:32AM  
Jan-09-20 08:39AM  
Jan-08-20 01:28PM  
Jan-06-20 04:03PM  
Jan-03-20 07:55AM  
Jan-02-20 04:01PM  
Dec-30-19 11:47AM  
10:17AM  
09:31AM  
Dec-27-19 12:05PM  
11:40AM  
10:26AM  
10:16AM  
Dec-26-19 11:42AM  
10:06AM  
Dec-24-19 09:28AM  
09:02AM  
Dec-23-19 09:15AM  
Dec-19-19 09:19AM  
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vitale LucasChief Human Resources OfficerAug 01Option Exercise0.0038607,590Aug 04 05:50 PM
Link MatthewPresidentJun 08Sale67.003,000201,00082,595Jun 10 05:52 PM
Vitale LucasChief Human Resources OfficerMar 01Option Exercise0.001,65207,483Mar 03 05:53 PM
SISITSKY NATHANIELSVP & General CounselMar 01Option Exercise0.001,586010,952Mar 03 05:51 PM
Link MatthewPresidentMar 01Option Exercise0.007,929088,010Mar 03 05:48 PM
LUCIER GREGORY TDirectorMar 01Option Exercise0.0033,6950235,915Mar 03 05:44 PM
Link MatthewPresidentJan 16Sale79.803,000239,40080,081Jan 17 05:53 PM
Link MatthewPresidentDec 24Option Exercise43.8812,760559,92191,708Dec 27 05:49 PM
Link MatthewPresidentDec 24Sale77.383,500270,83078,948Dec 27 05:49 PM
LUCIER GREGORY TDirectorNov 18Sale72.9929,4692,150,836202,220Nov 20 05:49 PM
McClintock PaulPresident, U.S. CommercialNov 11Sale72.043,314238,741400Nov 13 05:51 PM
Barry James ChristopherChief Executive OfficerNov 05Option Exercise0.0017,944017,944Nov 07 05:41 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.